Quantcast
Last updated on April 19, 2014 at 7:40 EDT

Latest Thrombolysis Stories

2012-02-03 19:00:24

An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. Jeffrey L. Saver at the American Stroke Association's 2012 international conference in New Orleans on Feb. 3. The SOLITAIRE Flow Restoration Device is among an entirely new generation of devices designed to remove blood clots from blocked brain arteries in patients experiencing stroke. It has a...

2012-02-03 19:00:01

An experimental blood clot-removing device outperformed the FDA-approved MERCI; retriever device, according to late-breaking science presented at the American Stroke Association´s 2012 International Stroke Conference. The SOLITAIRE; Flow Restoration Device is a self-expanding stent-based design that mechanically removes blood clots from blocked vessels after a stroke. After insertion into the clot using a thin tube, or catheter, the device traps the clot then both device and clot are...

2012-02-03 19:00:55

CT-guided catheters carry clot-busting drug to shrink clots, Johns Hopkins-led study shows Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull. The minimally invasive treatment, they report, increased the number of patients with intracerebral hemorrhage (ICH) who could function independently by 10 to 15 percent six months...

2012-02-01 12:32:42

Clot-busting drugs may be safe for patients who wake up experiencing stroke symptoms, according to preliminary research presented at the American Stroke Association's International Stroke Conference 2012. In "wake-up" stroke, the person wakes up with symptoms after going to sleep with none. Not knowing when the stroke began excludes these patients from anti-clotting drugs that must be given within 4.5 hours of the beginning of the stroke. "Because wake-up strokes are common, occurring...

2011-12-21 14:37:00

TAMPA, Fla., Dec. 21, 2011 /PRNewswire-USNewswire/ -- St. Joseph's Hospital Interventional Neuroradiologist Matthew Berlet, M.D. and Interventional Radiologist Glenn Stambo, M.D. are among the first in the county to treat acute ischemic stroke patients using a new device that rapidly restores blood flow to the brain. The Trevo(TM) is a minimally invasive catheter system that uses Stentriever(TM) technology to remove the blood clots that cause stroke. St. Joseph's is the only hospital in...

2011-12-19 07:00:00

REDMOND, Wash., Dec. 19, 2011 /PRNewswire/ -- Cerevast Therapeutics Inc., a privately held medical technology company, announced today that it has received CE mark clearance of its SonoLysis Headframe System, the Clotbust ER(TM)( )providing approval to commercialize the product in Europe. (Logo: http://photos.prnewswire.com/prnh/20111219/SF24705LOGO) The Clotbust ER(TM) is a first-in-class ultrasound device for the treatment of ischemic stroke, representing a novel...

2011-11-17 03:41:20

People with a history of stroke or diabetes who were given clot-busting drugs to break up blood clots after stroke fared better than those who did not receive the drugs, according to a study published in the November 16, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology. "The use of these drugs, called thrombolytic therapy, can limit damage and disability due to blood clots," said study author Kennedy R. Lees, MD, of the University of Glasgow in...

2011-11-14 23:31:00

A targeted, nanoparticle gelatin-based clot-busting treatment dissolved significantly more blood clots than a currently used drug in an animal study of acute coronary syndrome presented at the American Heart Association's Scientific Sessions 2011. The new drug-delivery system used gelatin to deactivate the clot-busting drug tissue plasminogen activator, or tPA, to treat acute coronary syndrome. Soundwaves were then used to reactivate tPA once it reached the blood clot. It is considered a...

2011-10-27 14:11:19

Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team. That is the key finding from a study published in the November issue of the European Journal of Neurology. Researchers from the Department of Neurology at Aarhus University Hospital in Denmark studied 306 patients admitted to the hospital with a TIA. They found...

2011-09-15 05:13:18

  (Ivanhoe Newswire) -- Patients who live in rural areas may have a new option for stroke care that doesn't involve traveling long distances. A new study found telemedicine for stroke, also known as "telestroke," appears to be cost-effective for rural hospitals that don't have an around-the-clock neurologist on staff. Researchers calculated the cost-effectiveness of telestroke by comparing the costs and quality-adjusted life years of stroke patients treated by telestroke to those...